Analysts See Drastic Change For This Particular Part Of Healthcare

Biotechs have emerged as an interesting option for investors. The State Street SPDR S&P Biotech ETF (XBI) broke out above a buy point last week and remains in that price area. The biotech fund is one of two ETFs in IBD Leaderboard. The S&P 500 Biotech index gapped up to nearly an all-time high last Wednesday, a bullish day for…